Basic nutrients
Omega-3 fatty acids
Amino acids
Minerals
Vitamins
Vitamin capsules
Liquid vitamins
Vitamin complex
Plant substances & superfoods
Antioxidants
Plant substances
Superfoods
Vital mushrooms
Functional nutrients
Enzymes & fiber
Melatonine
Probiotics
Bones, joints & muscles
Joints
Bones
Muscles
Weight loss & metabolism
Lose weight
Metabolism
Drainage
Mental health & performance
Memory & concentration
Stress, exhaustion & burnout
Mood
Sleep & fatigue
Energy
Sleep disorder
Iron deficiency
Heart health
Circulation
Heart protection
Blood pressure
Cholesterol
Women's health
Pregnancy & breastfeeding
Fertility
Hormone balance
PMS
Libido
Menopause
Recurrent cystitis
Men's health
Libido & erectile dysfunction
Prostate
Stomach & intestine
Intestinal cleansing & build-up
Digestive problems
Bloating
Heartburn
Hemorrhoids
Parasites
Beauty
Skin
Hair
Connective tissue
Liver health
Detoxification
Liver protection
Immune system
Strenghten the immune system
Allergy
Blood sugar
Eyes & eyesight
Inflammations
Histamine Intolerance
Pain
Longevity & cellular regeneration
Acid-base balance
Value packs
Card Value:
Qty
Discount:
You save:
Referral discount:
Grand Total:
Neu
Many people discover a narrowed artery only when a scan or an acute event forces the issue into view. In everyday life, there may have been no obvious warning: no pulling sensation, no clear pain, sometimes not even a blood‑pressure number that felt worrying. That can make the subject feel arbitrary — as if vessels simply fail without a pattern.
A stronger way to understand the problem is to step back from the visible end point. Arterial changes rarely begin as a sudden blockage. They often build gradually around three foundations: the inflammatory tone of the vessel wall, the ease with which blood flows at the microscopic level and the performance of the endothelium (the wafer-thin inner lining of the blood vessels) — the hair‑thin inner lining that regulates vascular tone (the resting tension of the blood vessel walls), nutrient exchange and platelet behaviour.
Those foundations are not dramatic in a single moment. They are cumulative. A quiet inflammatory signal can be sustained by diet patterns, oxidative stress (cell damage from unstable oxygen molecules (free radicals)) or metabolic load. Blood can become more prone to clotting structures and less free‑flowing as the fibrin (a protein in the blood that makes it clot) network becomes more prominent. The endothelium can generate less nitric oxide (a gas the body makes that widens the blood vessels) (NO), the small gas molecule that tells vessels when to relax, helps keep platelets from clumping and supports the normal anti‑adhesive surface of a healthy vessel lining. If those underlying areas are left unaddressed, the visible part of the story — a scan result, an episode, a new prescription — can seem like it arrived without cause.
This is the angle from which the Arteriosclerosis Stop Pack by Herbano® is built. It is not a claim that one capsule can correct a complex clinical condition. It is a routine organised around the everyday physiology that often sits beneath the surface: inflammatory balance, fibrin dynamics and endothelial NO biology. Each level receives its own product and its own dose space.
A vessel can feel mechanically normal and still experience a steady background of inflammatory signalling. That signal often does not announce itself. But in laboratory markers (for example, high‑sensitivity C‑reactive protein), in lipid composition and in how immune cells and platelets behave near the endothelium, the tone can be measured.
Omega‑3 long‑chain polyunsaturated fatty acids — especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from marine oils — sit inside that story not as stimulants or quick fixes, but as raw materials for membrane biochemistry. They become part of the phospholipid bilayer of the cells that make up the vascular wall and circulating immune cells. That matters because the lipid composition of those membranes influences which signalling molecules (the body's messenger substances that cells use to communicate) are produced when the body responds to ordinary stimuli.
When omega‑3 status is low and the omega‑6:omega‑3 ratio is high — a frequent pattern in typical Western eating — more of the mediators produced are of the pro‑inflammatory, pro‑aggregatory type (for example, thromboxane A2 and leukotriene B4). When EPA and DHA are present in greater proportion, the body has more material available for specialised pro‑resolving mediators such as resolvins and protectins. The point is not that inflammation (the body’s defence reaction, harmful when it becomes chronic) is “turned off”. The point is that resolution biochemistry has the raw materials it needs.
In parallel, omega‑3 intake consistently shows an effect on circulating triglycerides (blood fats) — a lipid fraction linked with metabolic status and cardiovascular risk. Human trials and meta‑analyses report that higher intakes of combined EPA/DHA can reduce fasting triglycerides in a clinically meaningful range and can shift several secondary markers in a direction associated with a calmer inflammatory environment.
Omega‑3 is therefore positioned at the level of the vessel‑wall signal. It provides structural lipids that influence mediator balance and, at appropriate intakes, reduces triglycerides — two levers that sit upstream of how a vessel “feels”.
Evidence context:
Everyday translation: A calmer vessel‑wall environment is not a sensation; it is a change in the chemistry of the surfaces and signals that regulate normal vascular function. For many readers, the first visible change is a lab number — usually triglycerides — with other effects felt more subtly over time as part of a broader routine and medical care plan.
Marine omega‑3 can be delivered as triglycerides, re‑esterified triglycerides or ethyl esters. Bioavailability (how much of a nutrient the body can actually absorb and use) differs modestly between forms and can be influenced by taking the product with meals containing fat. What matters most in everyday supplement choice is the declared combined amount of EPA + DHA per serving and the practical routine the person can sustain.
The pack uses a dedicated, high‑concentration fish‑oil omega‑3 product rather than a multi‑ingredient blend, so the EPA/DHA amount has space to be meaningful. Real‑world routines often target a combined EPA/DHA intake that is appropriate to the individual context and the advice of a healthcare professional. Taking omega‑3 with the main meal can reduce aftertaste and support absorption.
Note: Prescription‑only omega‑3 products and clinical endpoints in high‑risk populations are separate from food‑supplement claims. The pack positions omega‑3 at the level of nutritional biochemistry and normal physiology.
“Thick blood” is not a clinical term, but many people notice when circulation feels less easy: colder extremities in ordinary conditions, heavy legs on minor exertion or a sense that small injuries mark and bruise more obviously. Beneath those impressions often sit measurable changes in clot‑structure dynamics and microcirculatory flow. Fibrin — an insoluble protein formed from fibrinogen during the clotting cascade — is central to that micro‑structure.
Nattokinase is a serine protease enzyme derived from natto, a traditional Japanese food produced by fermenting soybeans with Bacillus subtilis. Its specific hook into this story is its fibrinolytic (dissolving fibrin, so clot-dissolving) activity: it can enhance the body’s own capacity to break down fibrin and can influence parameters linked to clot structure and lysis. It has also been observed to modulate plasmin and endogenous fibrinolytic pathways.
The relevance to everyday vascular comfort is straightforward: less excessive fibrin structure can mean an environment in which micro‑flow is easier and platelets are less prone to aggregate on a sticky surface. In observational and interventional work, nattokinase has been associated with changes in fibrin/fibrinogen degradation products, D‑dimer dynamics and euglobulin clot‑lysis time.
Evidence context: The human evidence base for nattokinase is smaller than for omega‑3 and varies in design and population. It includes mechanistic and surrogate‑endpoint studies that support the enzyme’s action on fibrin and parameters of fibrinolysis, with emerging work on vascular stiffness and selected lipid markers in specific cohorts.
Nattokinase products are typically standardised by fibrinolytic units (FU), reflecting enzymatic activity rather than milligrams of raw material. This distinction matters: an enzyme’s effect depends on its activity, not just its weight. Quality also depends on controlling vitamin K2 content (natto food is vitamin‑K‑rich, but a purified nattokinase ingredient for supplements can be specified for low K2), allergen handling for soy origin and protease stability across shelf life.
The pack uses a dedicated nattokinase product with activity standardised in FU. That gives the enzyme space for a meaningful activity declaration per serving, which is not realistic inside a cramped multi‑ingredient capsule.
Safety and interaction note: Because nattokinase interfaces with fibrinolysis, it belongs in a cautious conversation when a person uses anticoagulants (blood-thinning medicines), antiplatelet medicines, has a bleeding disorder, is preparing for surgery or is pregnant. Professional guidance is appropriate in those contexts. See the FAQ for a clear summary.
The endothelium is one of the body’s most quietly decisive surfaces. A single layer of cells, thinner than a strand of hair, lines every blood vessel. Among its many jobs is orchestrating vascular tone via nitric oxide (NO), generated by endothelial NO synthase (eNOS) from the amino acid L‑arginine.
When eNOS has the substrate it needs and its co‑factors are in balance, NO diffuses into the smooth‑muscle layer and signals relaxation. The vessel widens appropriately; shear stress is buffered; platelets are less inclined to adhere; the surface stays non‑stick; nutrient exchange is supported. When this system is under strain — oxidative stress, low substrate availability in relevant micro‑domains, or other common physiological stressors — the result can be a pattern often called endothelial dysfunction: reduced flow‑mediated dilation, less flexible responses to ordinary demands and a shift towards a more adhesive, pro‑aggregatory surface.
L‑arginine belongs here as the direct substrate for eNOS. Providing the raw material can, in defined contexts, improve flow‑mediated dilation (FMD) and support a normal vascular‑relaxation response. Human studies in specific groups have shown improved FMD and small but significant changes in blood‑pressure parameters over weeks of provision. The effect is physiological and substrate‑based, not pharmacological: it supplies the building block so a normal pathway can perform its ordinary task.
L‑arginine is used in gram quantities in research settings when endothelial function is the target, often split across the day. It is available as free‑base powder or as salts; the free‑base form keeps the declared milligrams focused on arginine itself. Tolerability is generally good in healthy adults, with occasional gastrointestinal softness at higher intakes. People with a history of herpes simplex may wish to discuss arginine intake with a clinician because arginine and lysine share metabolic intersections that are sometimes considered in that context.
The pack uses a standalone L‑arginine product formulated for straightforward, label‑directed dosing. Keeping arginine separate avoids shrinking the amount into a token inclusion within a crowded formula.
Important boundary: Improvements in endothelial function markers in research do not convert into a disease‑treatment claim for a food supplement. The pack positions arginine at the level of normal endothelial biology and routine nutritional provision.
Combination capsules can appear attractive: one product, several names on the label, a short routine. But capsule space is finite. Every additional active must share it. The result, frequently, is an impressive ingredients list with smaller amounts of each component than an evidence‑aware reader expects.
Many mechanisms relevant to vascular physiology simply do not fit into one small capsule at meaningful amounts: omega‑3 requires space for EPA/DHA, nattokinase requires enzymatic activity declared in fibrinolytic units, and L‑arginine belongs in gram‑range servings when endothelial function is the target. Compressing all three into one shell usually means reducing each to a token presence.
Herbano’s pack structure is therefore deliberate. Each component remains its own product with its own dose and purpose:
Because the broader real‑world complaint can involve all three levels at once, a routine that assigns each level its own product is more coherent than a single crowded formula. The value is conceptual, not only commercial: it makes the biology readable and the dose of each component intelligible.
Mandatory bundle principle in plain English: Many all‑in‑one capsules trade space for convenience. A long label does not automatically mean meaningful amounts. Using separate products lets each ingredient keep a clear role and a transparent serving.
A routine is only as strong as the habit that sustains it. The three‑part structure is designed to be practical, not theatrical:
None of those choices aims at a sudden, dramatic feeling. The point is continuity. Normal vascular physiology is a routine, not a one‑off event. The biology that makes this pack relevant is used by the body every hour of every day.
Readers often ask the right questions first: What exactly is in it? How much of the active ingredient is present? What form is used? What about allergens? Is the enzyme activity declared in units that matter? Those are the questions this pack is designed to answer clearly:
Each product is a single‑focus formula without unnecessary additions. That makes label reading easier: no token botanicals, no kitchen‑sink blends, no decorative names that compress the active to a small fraction of the capsule.
It is for readers who have recognised that visible endpoints often sit on top of quieter biology and who want to approach that biology with a structured, routine‑friendly plan. It is not a replacement for emergency care or for a clinician’s prescription when one is indicated.
Immediate medical attention is warranted if red‑flag symptoms occur. Examples include sudden chest pain or pressure; pain radiating into arm or jaw; sudden shortness of breath; cold sweat; acute visual disturbance; one‑sided weakness; slurred speech; or a new, severe leg pain with colour or temperature change. Those are emergency signs, not moments to reach for a supplement routine.
In day‑to‑day use by healthy adults, all three components are generally well tolerated. Minor, self‑limited effects are occasionally noticed when a routine begins or when servings are increased too quickly. Keep the following in view and discuss questions with a health professional where appropriate.
The routine is positioned as complementary to medical care, not as a replacement for it. Keep clinicians informed and use routine lab work and clinical check‑ins to assess the broader picture.
Nutrition and health‑claims rules in the UK set clear boundaries for what can be said about supplements. This page therefore explains mechanisms and cites human research where relevant, while keeping the language disciplined: effects are framed as contributions to normal physiology, not as treatments for disease. Prescription‑only outcomes and clinical endpoints are mentioned only to give context to the biology and to help readers understand why the three effect levels belong in the same conversation.
Bold signals on this page identify decision‑critical points: what each ingredient does at the level of normal function, why a separate product is used for each and how to think about dose as a routine rather than a single event.
These are illustrations, not diagnostic categories. They show how everyday observations can be read through the lens of normal body function and why a three‑level routine can make intellectual sense.
Consumers often face two extremes: a minimalist label that under‑delivers or a maximalist label that tries to impress with length. Neither helps if the amounts are not declared and appropriate. The better questions are:
This pack’s design is to make those answers easy: three separate products, each with its own label where the number is the point, not just an accessory to a long list of names.
Standing in front of a shelf, two nearly identical packs can feel impossible to tell apart. The better choice is not a claim of “premium”. It is a page that makes the reasoning visible: mechanism, role, dose logic, form and evidence context. That is what you have now: a three‑level routine explained through everyday physiology, with each product present because it has a specific job.
Omega‑3 for vessel‑wall tone and triglycerides; nattokinase for fibrin and micro‑flow; L‑arginine for endothelial NO and flow‑mediated dilation. Together they create a coherent routine that approaches a complex problem at the level where it often begins, not only where it first becomes visible.
Follow the directions on each individual Herbano® product label. This is a three‑component routine. The practical structure below reflects common patterns used in research and everyday practice, but your final schedule should remain aligned with the labelled instructions and any advice from a health professional.
Do not exceed the recommended daily dose.
Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
Store in a cool, dry place away from light. Keep out of reach of young children.
Composition:
The pack contains 3 separate preparations. Composition and amounts for each preparation:
Composition Omega 3 capsules high dose:
Fish oil, gelatine capsule (bovine gelatine, glycerine E422, water)
Thanks to the patented EPAX purification step, organic contaminants (e.g. dioxins, PCBs, heavy metals, iodine and pesticides) in the fish oil are reduced to the lowest possible level.
Quantities per capsule:
Composition of Nattokinase capsules:
cellulose powder, nattokinase, hydroxypropylmethylcellulose (vegan capsule shell), ascorbyl palmitate
Composition of L-arginine capsules:L-arginine base, hydroxypropylmethylcellulose (vegan capsule shell)
Quantities per capsule
Omega‑3 influences inflammatory signalling and triglycerides (blood fats); nattokinase belongs to fibrin (a protein in the blood that makes it clot) dynamics and micro‑flow; L‑arginine is the substrate for endothelial nitric‑oxide. These roles need space. A single small capsule cannot usually carry a meaningful EPA/DHA amount, a declared nattokinase activity in FU and a gram‑range substrate for eNOS all at once. Keeping them separate lets each product reach a sensible serving and keeps the routine intelligible.
This routine is built for normal physiology over time. Omega‑3 effects are commonly first visible in lab triglycerides. Endothelial‑function changes with L‑arginine are measured in flow‑mediated dilation, not as a sudden sensation. Nattokinase acts on fibrin parameters that are not felt directly. Expect a routine that supports the background environment, not an instant “boost”.
Many people use nutrition alongside medical care. However, nattokinase interfaces with fibrinolysis and warrants a clinician’s input if you use anticoagulants (blood-thinning medicines) or antiplatelet medicines, have a bleeding disorder, or are scheduled for surgery. Let your healthcare professional know about all supplements and follow their advice.
All three products are generally well tolerated in healthy adults. Potential, usually mild experiences include: - Omega‑3: fishy aftertaste or burping if taken away from meals - L‑arginine: softer stools or mild gastrointestinal discomfort at higher intakes - Nattokinase: rare easy bruising in sensitive individuals. Stop use and seek advice if unexpected symptoms occur.
Omega‑3 can influence platelet behaviour and eicosanoid balance. It is not an anticoagulant medicine. Use it as directed on the label. If you are under the supervision of a complementary practitioner or naturopath for bleeding risk or take anticoagulants or antiplatelets, ask your clinician before use.
Traditional natto food is rich in vitamin K2 (MK‑7). Purified nattokinase raw materials for supplements can be specified for low K2 content. The Herbano® nattokinase ingredient is selected and standardised for enzymatic activity (FU), with vitamin K managed per specification. If you are on vitamin‑K‑sensitive medication, discuss supplement use with your clinician.
Nattokinase is derived from fermented soybeans. Soy origin is transparently declared. Individuals with soy allergy should consult an allergist or clinician before use and read the label carefully.
Arginine and lysine share metabolic intersections that some clinicians consider in the context of recurrent (coming back again and again) herpes simplex. If you have a history of frequent episodes, discuss arginine use and total dietary context with your healthcare professional.
Call emergency services immediately. Sudden chest pressure; pain into arm or jaw; shortness of breath; cold sweat; acute visual change; one‑sided weakness; slurred speech; or new, severe leg pain are medical emergencies. Supplements are not appropriate in an acute situation.
Sources (in English):
AbuMweis S et al. (2018). Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis (a study that pools the results of many studies) of randomised placebo (a dummy treatment used for comparison)-control human clinical trials. Journal of Functional Foods. https://pubmed.ncbi.nlm.nih.gov/29276556/
Bai Y et al. (2009). Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/19297459/
Chen H et al. (2022). Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases. Biomarker Insights. https://pubmed.ncbi.nlm.nih.gov/29434476/
Ren NN et al. (2017). A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia. Zhonghua Yi Xue Za Zhi. https://pubmed.ncbi.nlm.nih.gov/28763875/
Rizos EC et al. (2012). Association between omega-3 fatty acid supplementation (topping up a substance the body is short of) and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. https://pubmed.ncbi.nlm.nih.gov/22968891/
Thank you for your feedback. Your review will be released shortly.
Arteriosclerosis Stop Pack by Herbano® – Omega‑3 + Nattokinase + L‑Arginine